VitD3 Supplementation in Patients With Multiple Myeloma
VitD3 Supplementation in Patients With Multiple Myeloma
Recruiting · NCT05846880 · Registry updated 2025-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VitD3 Supplementation in Patients With Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, nutritional deficiency disease, nutritional disorder, plasma cell neoplasm, vascular disorder, vascular hemostatic disease, vitamin D deficiency, vitamin deficiency disorder | Recruiting | Early phase 1 | 2025-04-08 | NCT05846880 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amany Keruakous, MD, MS. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Georgia Cancer Center at Augusta University | Augusta | United States | 23 |